The Scholar Hosts for 2004 are:
Christine B. Ambrosone, Ph.D.
Chair, Department of Epidemiology
Division of Cancer Prevention & Population Sciences
Roswell Park Cancer Institute
Buffalo, N.Y.
Effect of Genetic and Lifestyle Factors on Response to Treatment for Breast Cancer
David M. Livingston, M.D.
Deputy Director, Dana-Farber Cancer Institute/Harvard Cancer Center
Emil Frei Professor of Genetics and Medicine
Harvard Medical School
Department of Cancer Biology
Boston, Mass.
Functional Significance of the BRCA1/Xist Interaction: Reactivation of Silenced X-Linked Genes in Breast and Ovarian Cancer
Bonnie F. Sloane, Ph.D.
Director, Breast Cancer Center of Excellence
Professor and Chair
Department of Pharmacology
School of Medicine
Wayne State University
Detroit, Mich.
Validation of Proteases as Therapeutic Targets in Breast Cancer: Functional Imaging of Protease
Expression, Activity, and Inhibition
Ann D. Thor, M.D.
Lloyd E. Rader Professor and Chair, Department of Pathology
Thor Lab of the Breast Cancer Research Program of the OU Cancer Center
University of Oklahoma Health Sciences Center
Oklahoma City, Okla.
E2 Modulation of Tumorigenesis in erbB-2 Transgenic Mice
The Scholar Hosts for 2005 are:
Robert B. Dickson, Ph.D.
Professor of Oncology, Co-Director, Georgetown University Breast Cancer Program
Nina Hyde Center for Breast Cancer Research
Lombardi Comprehensive Cancer Center, Georgetown University
Washington, D.C.
Molecular Determinants of the Onset and Progression of Breast Cancer
Margot M. Ip, Ph.D.
Professor and Member
Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, N.Y.
Prevention of Breast Cancer Progression with Conjugated Linoleic Acid (CLA)
Regina M. Santella, Ph.D.
Professor of Environmental Health Sciences
Department of Environmental Health Sciences
Columbia University Mailman School of Public Health
New York, N.Y.
Gene-Environment Interaction in Breast Cancer Etiology and Prognosis
Eric J. Stanbridge, Ph.D.
Distinguished Professor
Microbiology and Molecular Genetics
University of California, Irvine College of Medicine
Irvine, Calif.
Gene Therapy for Breast Cancer: Targeting Hypoxic Cells
This program is open to Principal Investigators engaged in basic, translational, clinical, epidemiological, or prevention breast cancer research at NCI-designated cancer centers or cancer centers that are members of the Association of American Cancer Institutes.
These International Scholar Awards have been established to enhance the quality of cancer research and clinical breast care for women in countries where opportunities for specialized scientific training and advancement for physicians and scientists are limited, with special emphasis on such countries in Asia, Latin America, and Eastern Europe.
The objective of the program is to better equip the Scholars with the skills and knowledge needed to implement and/or continue a successful program of breast cancer research in their home country, ultimately leading to the improved care of cancer patients. The program will accomplish this objective by placing each Scholar under the mentorship of a top breast cancer scientist at a leading academic research institution within the United States where she/he will engage in an outstanding program of cancer research and experience unique professional development opportunities.
Principal Investigators chosen as Scholar Hosts will benefit from the unique contributions of a talented scientist to their research program, and will experience the personal and professional satisfaction of contributing to the development of a potential future leader in breast cancer research from an area of the world where opportunities for scientific training and advancement are limited.
Each host institution will receive an annual grant to support a salary for the Scholar; direct research expenses; institutional expenses, such as travel to and from the home country and other relevant expenses not directly related to research; and a stipend to cover award administration. Scholars will receive travel grants to support their attendance at two AACR Annual Meetings, and a complimentary AACR Active membership.
The Avon Foundation-AACR International Scholars in Breast Cancer Research is funded by a $2.8 million gift from the Avon Foundation to encourage and promote breast cancer research and education, particularly among young investigators in underserved countries. The gift is one element of the Avon Foundation-AACR Global Partnership in Breast Cancer Research and Education, which also is supporting the international component of the AACR Scientist?Survivor Program and the Avon Foundation-AACR International Scholar-in-Training Awards.
A Call for Applications from those junior faculty members who wish to apply for the program will be issued in May 2004. The deadline for applications is July 1, 2004. For more information, please visit the AACR website at www.aacr.org.
Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 22,000 laboratory and clinical scientists engaged in basic, translational, and clinical cancer research in the United States and over 60 other countries. The AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). The AACR's Annual Meeting attracts more than 16,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational, and clinical cancer research.